Placenta accreta spectrum – variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study
| dc.contributor.author | McCall, Stephen J. | |
| dc.contributor.author | Tharaux-Deneux, Catherine | |
| dc.contributor.author | Sentilhes, Loïc | |
| dc.contributor.author | Ramakrishnan, Rema | |
| dc.contributor.author | Collins, Sally L. | |
| dc.contributor.author | Seco, Aurélien | |
| dc.contributor.author | Kurinczuk, Jennifer J. | |
| dc.contributor.author | Knight, Marian | |
| dc.contributor.author | Kayem, Gilles | |
| dc.contributor.department | Center for Research on Population and Health (CRPH) | |
| dc.contributor.faculty | Faculty of Health Sciences (FHS) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T12:17:14Z | |
| dc.date.available | 2025-01-24T12:17:14Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Objective: To compare the management and outcomes of women with placenta accreta spectrum (PAS) in France and the UK. Design: Two population-based cohorts. Setting: All obstetrician-led hospitals in the UK and maternity hospitals in eight French regions. Population: A cohort of 219 women with PAS in France and a cohort of 154 women with PAS in the UK. Methods: The management and outcomes of women with PAS were compared between the UK and France. Main outcome measures: Median blood loss, severe postpartum haemorrhage (≥3 l), postpartum infection and damage to surrounding organs. Results: The management of PAS differed between the two countries: a larger proportion of women with PAS in the UK had a caesarean hysterectomy compared with France (43% vs 26%, p < 0.001), whereas in France a larger proportion of women with PAS received a uterus-preserving approach compared with the UK (36% vs 19%, p < 0.001). The total median blood loss in the UK was 3 l (IQR 1.7–6.5 l), compared with 1 l (IQR 0.5–2.5 l) in France; more women with PAS had a severe postpartum haemorrhage (PPH) in the UK compared with women with PAS in France (58% vs 21%, p < 0.001) [Correction added on 06 May 2022, after first online publication: ‘24 hour’ has been changed to ‘total’ in the preceding sentence]. There was no difference between the UK and French populations for postpartum infection or organ damage. Conclusions: The UK and France have very different approaches to managing PAS, with more women in France receiving a uterine-conserving approach and more women in the UK undergoing caesarean hysterectomy. A life-threatening haemorrhage was more common in the UK than in France, which may be the result of differential management and/or the organisation of the healthcare systems. In women with placenta accreta spectrum, severe haemorrhage was more common in the UK than in France. Tweetable abstract: In women with placenta accreta spectrum, severe haemorrhage was more common in the UK than in France. © 2022 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd. | |
| dc.identifier.doi | https://doi.org/10.1111/1471-0528.17169 | |
| dc.identifier.eid | 2-s2.0-85129082384 | |
| dc.identifier.pmid | 35384244 | |
| dc.identifier.uri | http://hdl.handle.net/10938/33714 | |
| dc.language.iso | en | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.relation.ispartof | BJOG: An International Journal of Obstetrics and Gynaecology | |
| dc.source | Scopus | |
| dc.subject | Conservative management | |
| dc.subject | Haemorrhage | |
| dc.subject | Hysterectomy | |
| dc.subject | Management | |
| dc.subject | Placenta accreta spectrum | |
| dc.subject | Cesarean section | |
| dc.subject | Female | |
| dc.subject | Humans | |
| dc.subject | Placenta accreta | |
| dc.subject | Postpartum hemorrhage | |
| dc.subject | Pregnancy | |
| dc.subject | Retrospective studies | |
| dc.subject | United kingdom | |
| dc.subject | Adult | |
| dc.subject | Article | |
| dc.subject | Clinical feature | |
| dc.subject | Clinical practice | |
| dc.subject | Cohort analysis | |
| dc.subject | Comparative study | |
| dc.subject | Controlled study | |
| dc.subject | France | |
| dc.subject | Human | |
| dc.subject | Human cell | |
| dc.subject | Infant | |
| dc.subject | Major clinical study | |
| dc.subject | Maternal morbidity | |
| dc.subject | Outcome assessment | |
| dc.subject | Patient care | |
| dc.subject | Puerperal infection | |
| dc.subject | Retrospective study | |
| dc.title | Placenta accreta spectrum – variations in clinical practice and maternal morbidity between the UK and France: a population-based comparative study | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1